Charles River Laboratories International, Inc.
CRL
$162.85
-$5.84-3.46%
NYSE
| 03/28/2026 | 12/27/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 191.83M | 213.77M | 207.10M | 182.82M | 229.36M |
| Total Receivables | 700.25M | 708.86M | 734.48M | 767.57M | 756.63M |
| Inventory | 359.72M | 299.10M | 302.55M | 279.55M | 290.16M |
| Prepaid Expenses | 102.15M | 96.11M | 121.54M | 110.00M | 129.99M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 134.86M | 129.21M | 166.44M | 129.92M | 100.23M |
| Total Current Assets | 1.49B | 1.45B | 1.53B | 1.47B | 1.51B |
|
|
|||||
| Total Current Assets | 1.49B | 1.45B | 1.53B | 1.47B | 1.51B |
| Net Property, Plant & Equipment | 1.83B | 2.02B | 1.97B | 1.99B | 1.99B |
| Long-term Investments | 3.04B | 2.76B | 2.92B | 2.94B | 2.87B |
| Goodwill | 3.04B | 2.76B | 2.92B | 2.94B | 2.87B |
| Total Other Intangibles | 248.99M | 340.00M | 571.09M | 602.45M | 655.71M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 914.76M | 360.52M | 327.80M | 343.40M | 342.90M |
| Total Assets | 7.73B | 7.14B | 7.51B | 7.56B | 7.58B |
|
|
|||||
| Total Accounts Payable | 133.95M | 148.80M | 169.62M | 145.80M | 149.33M |
| Total Accrued Expenses | 509.29M | 508.94M | 470.53M | 432.95M | 414.79M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.29M | 61.06M | 2.64M | 2.93M | 3.47M |
| Total Finance Division Other Current Liabilities | 442.18M | 401.52M | 479.11M | 498.76M | 483.46M |
| Total Other Current Liabilities | 442.18M | 401.52M | 479.11M | 498.76M | 483.46M |
| Total Current Liabilities | 1.09B | 1.12B | 1.12B | 1.08B | 1.05B |
|
|
|||||
| Total Current Liabilities | 1.09B | 1.12B | 1.12B | 1.08B | 1.05B |
| Long-Term Debt | 2.65B | 2.11B | 2.16B | 2.31B | 2.49B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 402.16M | 458.70M | 468.66M | 479.38M | 500.82M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 592.05M | 233.51M | 312.47M | 294.48M | 303.66M |
| Total Liabilities | 4.74B | 3.92B | 4.06B | 4.16B | 4.34B |
|
|
|||||
| Common Stock & APIC | 1.97B | 1.95B | 2.02B | 1.99B | 1.98B |
| Retained Earnings | 1.37B | 1.39B | 1.94B | 1.89B | 1.84B |
| Treasury Stock & Other | -401.03M | -171.78M | -555.05M | -529.81M | -621.80M |
| Total Common Equity | 2.94B | 3.16B | 3.41B | 3.35B | 3.19B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.94B | 3.16B | 3.41B | 3.35B | 3.19B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 47.72M | 46.56M | 45.37M | 46.27M | 47.45M |
| Total Equity | 2.99B | 3.21B | 3.45B | 3.40B | 3.24B |
|
|
|||||